Learning impairment after three classes of agents which modify cholinergic function.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003213:Conditioning, Psychological / Q000187:drug effects; D003864:Depression, Chemical; D004327:Drinking Behavior / Q000187:drug effects; D005239:Fear / Q000187:drug effects; D007858:Learning / Q000187:drug effects*; D008297:Male; D008464:Mecamylamine / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009281:Naphthalenes / Q000008:administration & dosage / Q000494:pharmacology*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology*; D014753:Vinyl Compounds / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D009281:Naphthalenes; D010276:Parasympatholytics; D011725:Pyridines; D014753:Vinyl Compounds; D008464:Mecamylamine; D012601:Scopolamine